Published in Tokai J Exp Clin Med on January 01, 1986
Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature (1977) 2.58
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Ann Oncol (2007) 1.54
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. Ann Oncol (2011) 1.49
[Cytokine production in patients with systemic lupus erythematosus]. Orv Hetil (1991) 1.38
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Ann Oncol (2009) 1.26
ATP induces a conformational change of the 90-kDa heat shock protein (hsp90). J Biol Chem (1993) 1.23
Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (2000) 1.21
Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis (2007) 1.18
The three-dimensional structure of human transaldolase. FEBS Lett (2000) 1.17
Lymphocyte surface immunoglobulins in autoimmune diseases. Lancet (1973) 1.11
Effector activity of OKT4+ and OKT8+ T-cell subsets in lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells. Cell Immunol (1984) 1.10
Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C. FASEB J (2000) 1.08
Fc receptors on human blood B lymphocytes. Clin Exp Immunol (1977) 1.07
Characterization of cytotoxic human lymphocyte subpopulations: the role of Fc-receptor-carrying cells. Cell Immunol (1977) 1.04
Characterization of human lymphocyte subpopulations for cytotoxicity against tumor-derived monolayer cultures. Int J Cancer (1977) 1.03
Study of the subunit interactions in myosin phosphatase by surface plasmon resonance. Eur J Biochem (2000) 1.00
Synthesis and pharmacological evaluation of some new tetrahydroisoquinoline derivatives inhibiting dopamine uptake and/or possessing a dopaminomimetic property. J Med Chem (1986) 1.00
Inhibition of serine/threonine-specific protein phosphatases causes premature activation of cdc2MsF kinase at G2/M transition and early mitotic microtubule organisation in alfalfa. Plant J (2000) 1.00
Aldehyde bisulfite-toluidine blue (ABT) staining as a topo-optical reaction for demonstration of linear order of vicinal OH groups in biological structures. Histochemistry (1975) 0.99
Pathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation. Cell Mol Life Sci (2005) 0.99
Attenuated veterinary virus vaccine for the treatment of cancer. Cancer Detect Prev (1993) 0.99
HBsaG in renal disease. Lancet (1978) 0.98
T and B lymphocytes in pregnancy. Klin Wochenschr (1974) 0.97
Submicroscopic investigation of homologous tendon grafts preserved by means of different methods. Acta Morphol Acad Sci Hung (1973) 0.96
Detection and mapping of polymorphic KpnI alleles in the human T-cell receptor constant beta-2 locus. Immunology (1989) 0.95
Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis. A comparative study of 270 cases. Z Rheumatol (2003) 0.93
Effect of ethyl apovincaminate on the cerebral circulation. Serial angiography and regional cerebral circulation studies in neurosurgical patients. Arzneimittelforschung (1976) 0.93
Measurement of intracellular interferon-gamma and interleukin-4 in whole blood T lymphocytes from patients with systemic lupus erythematosus. Immunol Lett (2000) 0.92
Identification and localization of myosin phosphatase in human platelets. Biochem J (1998) 0.91
Reactive oxygen species mediate phorbol ester-regulated tyrosine phosphorylation and phospholipase A2 activation: potentiation by vanadate. Biochem J (1993) 0.90
Functional and morphological macular abnormalities in membranoproliferative glomerulonephritis type II. Br J Ophthalmol (2010) 0.90
The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma. Cancer (2000) 0.89
Effect of fructose 1-phosphate on the activation of liver glycogen synthase. Biochem J (1985) 0.89
Spontaneous and PHA-induced rosetting of human blood, tonsil lymphocytes and MLC blasts with sheep, human and horse erythrocytes. Clin Exp Immunol (1976) 0.89
Peroxynitrite production, DNA breakage, and poly(ADP-ribose) polymerase activation in a mouse model of oxazolone-induced contact hypersensitivity. J Invest Dermatol (2001) 0.89
The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies. Clin Nephrol (1979) 0.88
Association between early onset and organ manifestations of systemic lupus erythematosus (SLE) and a down-regulating promoter polymorphism in the MBL2 gene. Clin Immunol (2007) 0.88
Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme. Acta Physiol Hung (1991) 0.88
Effects of two bioflavonoids on certain cellular immune reactions in vitro. Acta Physiol Hung (1990) 0.88
Antibody dependent and spontaneous lymphocyte mediated cytotoxicity in normal subjects, patients with SLE, and malignancies. Acta Med Acad Sci Hung (1977) 0.87
Interaction between immunity to Bordetella bronchiseptica and infection of pig herds by Bordetella bronchiseptica and Pasteurella multocida. J Vet Med Sci (1993) 0.87
Dephosphorylation of distinct sites on microtubule-associated protein MAP1B by protein phosphatases 1, 2A and 2B. FEBS Lett (1993) 0.87
Endothall thioanhydride inhibits protein phosphatases-1 and -2A in vivo. Am J Physiol (1995) 0.87
Permanent large granular lymphocytosis in the blood of splenectomized individuals without concomitant increase of in vitro natural killer cell cytotoxicity. Clin Exp Immunol (1986) 0.86
Symptoms of endocrine treatment and outcome in the BIG 1-98 study. Breast Cancer Res Treat (2013) 0.86
Effect of bisphosphonate treatment in patients with Paget's disease of the skull. Rheumatology (Oxford) (2003) 0.85
Partial protection by poly(ADP-ribose) polymerase inhibitors from nitroxyl-induced cytotoxity in thymocytes. Free Radic Biol Med (2001) 0.85
Efficient inhibition of muscle and liver glycogen phosphorylases by a new glucopyranosylidene-spiro-thiohydantoin. Bioorg Med Chem Lett (1999) 0.85
Human lectin-dependent T cell-mediated cytotoxicity against Hep-2 cells. Acta Physiol Hung (1983) 0.85
[Liver-protective action of silymarin therapy in chronic alcoholic liver diseases]. Orv Hetil (1989) 0.85
Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors. Scand J Rheumatol (2007) 0.85
Role of HLA-DRB1 and PTPN22 genes in susceptibility to juvenile idiopathic arthritis in Hungarian patients. Clin Exp Rheumatol (2009) 0.84
Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial. Br J Cancer (2013) 0.84
Controlled trial of vitamin A therapy in gastric ulcer. Lancet (1982) 0.84
Investigation of cytokine (tumor necrosis factor-alpha, interleukin-6, interleukin-10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus. Eur J Neurol (2004) 0.84
Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: a phase 2 study. Eur J Cancer (2013) 0.84
A comparative dynamic study of the effectiveness of gastric cytoprotection by vitamin A, De-Nol, sucralfate and ulcer healing by pirenzepine in patients with chronic gastric ulcer (a multiclinical and randomized study). Acta Physiol Hung (1984) 0.84
Prevalence of obesity in an elderly Hungarian population. Eur J Epidemiol (2003) 0.83
Clinical and pathological effects of the dermonecrotic toxin of Bordetella bronchiseptica and Pasteurella multocida in specific-pathogen-free piglets. Nihon Juigaku Zasshi (1990) 0.83
Interaction between iron(II) and hydroxamic acids: oxidation of iron(II) to iron(III) by desferrioxamine B under anaerobic conditions. J Inorg Biochem (2001) 0.83
Epstein-Barr-virus immunity and tissue distribution in a fatal case of infectious mononucleosis. N Engl J Med (1978) 0.83
Immunohistochemical localisation of two phosphatidylinositol 4-kinase isoforms, PI4K230 and PI4K92, in the central nervous system of rats. Exp Brain Res (2000) 0.83
The control of phosphorylase phosphatase by cAMP-dependent protein kinase. FEBS Lett (1977) 0.83
Studies on T and B lymphocytes in the peripheral blood of discoid lupus erythematosus patients with and without chloroquine treatment. Acta Derm Venereol (1976) 0.83
Serum 25(OH)-vitamin D levels and bone metabolism in patients on maintenance hemodialysis. Clin Nephrol (2005) 0.83
Fragmentation study of rutin, a naturally occurring flavone glycoside cationized with different alkali metal ions, using post-source decay matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom (2001) 0.82
Purification and characterization of three distinct types of protein phosphatase catalytic subunits in bovine platelets. Arch Biochem Biophys (1992) 0.82
Separation of rabbit liver latent and spontaneously active phosphorylase phosphatases by chromatography on heparin-sepharose. Biochem Biophys Res Commun (1985) 0.82
Stimulation of lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells by carrageenan. Clin Exp Immunol (1983) 0.82
Phosphorylation of MYPT1 by protein kinase C attenuates interaction with PP1 catalytic subunit and the 20 kDa light chain of myosin. FEBS Lett (2000) 0.81
[Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)]. Orv Hetil (1990) 0.81
Letter: Rosette stimulation by plant mitogens. Lancet (1973) 0.81
A simple assay for tumor necrosis factor using HEp-2 target cells. J Clin Lab Immunol (1989) 0.81
Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus. J Rheumatol (2001) 0.81
Enhancement of mitogen-induced lymphocyte proliferation after preincubation is due to altered sensitivity to prostaglandins. Immunol Lett (1982) 0.81
Protein phosphatase 2A holoenzyme and its subunits from Medicago sativa. Plant Mol Biol (2000) 0.81
Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines. Scand J Rheumatol (2008) 0.81
Letter: Hepatitis-B antigenaemia associated with progressive cirrhosis and membranous glomerulonephritis. Lancet (1975) 0.81
Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus. J Clin Lab Immunol (1984) 0.81
[Fibro-osseous lesion of the central nervous system]. Orv Hetil (2001) 0.81
Functional analysis of the Neurospora crassa PZL-1 protein phosphatase by expression in budding and fission yeast. Yeast (2001) 0.81
Vitamin D receptor, oestrogen receptor-alpha and calcium-sensing receptor genotypes, bone mineral density and biochemical markers in Paget's disease of bone. Rheumatology (Oxford) (2004) 0.80
Insoluble glycogen and its interaction with phosphorylase. A novel method for the purification of liver phosphorylase A. Acta Biochim Biophys Hung (1987) 0.80
Lymphocyte surface immunoglobulins in Hodgkin's disease. N Engl J Med (1973) 0.80
Human blood lymphocyte fractionation with special attention to their cytotoxic potential. Z Immunitatsforsch Immunobiol (1978) 0.80
The submicroscopic structure of collagen fibers as revealed by topooptical staining reactions with cationic dyes. Acta Morphol Acad Sci Hung (1967) 0.80
Usefulness of detection of complement activation products in evaluating SLE activity. Lupus (2000) 0.80